Radioactive peptide that nukes cancer cells succeeds in Phase 3 trial
surmenok · x · 2026-10-14
A radioactive peptide that targets cancer cells and delivers radiation to destroy them has succeeded in a Phase 3 trial, per Superpower. The news was amplified with a bio/acc framing: "they invented peptides that literally nuke cancer."
More from Research
- NTU team has Claude write robot control code, hitting 70.24% success in sim — aigclink · 2026-10-14
- Six training strategies compared: can LLMs reason over graphs at scale? — burkov · 2026-10-14
- VisInteract: NeurIPS Spotlight reframes text-to-visualization as multi-turn intent retrieval — jiqizhixin · 2026-10-14
- WorldRecon reconstructs large-scale 3D scenes from unposed multi-view images, cutting Chamfer distance 43% — ZhejiangUniversity · 2026-10-14
- RSI-Nav: recursive self-improvement for navigation agents hits 68.6% SR on R2R-CE — OpenGVLab · 2026-10-14
- NUS proposes Jeva, a decision-native architecture with near-perfect null detection at thousands of candidates — NationalUniversityofSingapore · 2026-10-14